[1]
Romano, M. et al. 2014. Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients. Reumatismo. 65, 6 (Mar. 2014), 278–285. DOI:https://doi.org/10.4081/reumatismo.2013.682.